Abundance Wealth Counselors Purchases 3,215 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Abundance Wealth Counselors increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 184,993 shares of the exchange traded fund’s stock after buying an additional 3,215 shares during the period. SPDR S&P Biotech ETF comprises 3.6% of Abundance Wealth Counselors’ portfolio, making the stock its 5th largest holding. Abundance Wealth Counselors owned approximately 0.24% of SPDR S&P Biotech ETF worth $16,660,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Avior Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $44,000. Finally, Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $49,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $92.67 on Friday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a 50-day simple moving average of $93.24 and a 200-day simple moving average of $96.72. The stock has a market capitalization of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.